Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 in Stock

4 days ago · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,553 shares of the firm's stock in a transaction dated Wednesday, January 8th. The shares …

$261820.57
OFF

Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 In Stock

2 weeks from now

4 days ago · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,553 shares of the firm's stock in a transaction dated Wednesday, January 8th. The shares …

marketbeat.com

$236217.37
OFF

Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $236,217.37 In Stock

2 weeks from now

Jan 7, 2025 · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,061 shares of the business's stock in a transaction that occurred on Monday, January 6th. …

insidertrades.com

$150603205.68
OFF

Arcellx (ACLX) Insider Trading Activity 2025 - MarketBeat

2 weeks from now

6 days ago · How much insider selling is happening at Arcellx? Insiders have sold a total of 2,900,417 Arcellx shares in the last 24 months for a total of $150,603,205.68 sold. Arcellx Key …

marketbeat.com

$2263942
OFF

Arcellx Insider Sold Shares Worth $2,263,942

2 weeks from now

2 days ago · Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing January 13, 2025 at 03:23 am EST ... Arcellx, Inc. is a clinical-stage biotechnology company. …

marketscreener.com

$261820.57
OFF

Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 In Stock

2 weeks from now

5 days ago · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,553 shares of the company's stock in a transaction that occurred on Wednesday, January …

insidertrades.com

$2.26
OFF

Arcellx CEO Elghandour Sells Stock Worth $2.26 Million

2 weeks from now

6 days ago · arcellx CEO Elghandour sells stock worth $2.26 million. Rami Elghandour, President, CEO, and Chairman of the Board of Arcellx, Inc. (NASDAQ:ACLX), has sold a significant …

investing.com

$54466094.78
OFF

ACLX Insider Trading | Arcellx Buys And Sells

2 weeks from now

Insider Selling (Last 12 Months): $54,466,094.78 Arcellx Insider Trading History Chart This chart shows the insider buying and selling history at Arcellx by year and by quarter.

insidertrades.com

$98805.00
OFF

Arcellx, Inc. (NASDAQ:ACLX) Director Sells $98,805.00 In Stock

2 weeks from now

1 day ago · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) Director Kavita Patel sold 1,500 shares of the firm's stock in a transaction on Tuesday, January 14th. The stock was sold at an …

insidertrades.com

$1355024
OFF

Arcellx Insider Sold Shares Worth $1,355,024

2 weeks from now

2 days ago · Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing January 13, 2025 at 03:23 am EST ... Arcellx, Inc. is a clinical-stage biotechnology company. …

marketscreener.com

FAQs about Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 in Stock Coupon?

How many research reports have been made about arcellx?

Arcellx has only been the subject of 4 research reports in the past 90 days. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. ...

Where can I find more information about Arcellx?

For more information on Arcellx, please visit www.arcellx.com . Arcellx is a company that... Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. ...

Is arcellx (arcellx) a good stock to buy?

Arcellx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $43.36, Arcellx has a forecasted upside of 40.7% from its current price of $30.81. ...

Should investors buy arcellx (aclx) stock?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcellx in the last twelve months. There are currently 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACLX shares. View ACLX analyst ratings or view top-rated stocks. ...

How many investors does Arcellx have?

Arcellx has 25 investors, including Kite Pharma and Suvretta Capital Management. ...

Where can I buy aclx stock?

Shares of ACLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. ...